BD Corp. To Invest $300 Mil. In Safety-Engineered Protection Devices
This article was originally published in The Gray Sheet
Executive Summary
BD Corp. says it will invest $300 mil. in its Advanced Protection Technologies line of safety-engineered protection devices during fiscal year 2001.
You may also be interested in...
BD To Achieve Safety Products Sales Target Early Aided By OSHA Revision
The Needlestick Safety and Prevention Act and subsequent revision to the Occupational Safety and Health Administration's bloodborne pathogens standard will help BD Corp. reach the $800 mil. sales mark by the end of 2003, the firm is now projecting, well ahead of its earlier forecast of 2005.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.